Physician profile
Robert J Obermeyer
NPI 1104832542
$843,754.91
in general payments reported to CMS, 2019-2025
12 companies · $153K in 2025
The $153K reported for 2025 was more than what 99% of Pediatric Surgery providers received nationally (typical 2025 total: $136).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,231 · 2020: $319 · 2021: $3,671 · 2022: $6,532 · 2023: $321K · 2024: $358K · 2025: $153K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $793K · Consulting Fee: $26K · Travel and Lodging: $9,091 · Education: $2,500 · Food and Beverage: $1,271.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $792,716.45 |
| Consulting Fee | $26,425.00 |
| Travel and Lodging | $9,090.88 |
| Education | $2,500.00 |
| Food and Beverage | $1,270.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $807,959.35 | 2019-2025 | Medline, Nexgen, Advantagerib |
| Atricure, INC. | $25,368.76 | 2022-2025 | Atricure Cryoice Cryosphere Cryoablation System, Atricure Cryoice Cryoablation System (Cryo2) |
| L&K Biomed Co. , LTD. | $5,293.00 | 2025 | Castleloc Pectus System |
| Intuitive Surgical, INC. | $3,559.96 | 2023 | Davinci Xi, Da Vinci Surgical System |
| Zimvie INC. | $1,227.09 | 2022 | |
| Kerecis Limited | $134.69 | 2024-2025 | Kerecis Surgiclose, Kerecis Omega3 Marigen, Kerecis Graftguide |
| Solventum Corporation | $74.74 | 2024-2025 | V.A.C. Dermatac, V.A.C. Veraflo Cleanse Choice, Prevena |
| Medtronic, INC. | $39.90 | 2024-2025 | Endo Gia Ultra, Signia |
| Avita Medical Americas, LLC | $33.13 | 2025 | Permeaderm, Recell, Cohealyx |
| Olympus America INC. | $23.33 | 2019 | |
| Bard Peripheral Vascular, INC. | $22.42 | 2021 | |
| Stryker Corporation | $18.54 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Obermeyer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.